🇺🇸 FDA
Patent

US 6811787

Over-expressing homologous antigen vaccine and a method of making the same

expired A61KA61K2039/522A61K39/00

Quick answer

US patent 6811787 (Over-expressing homologous antigen vaccine and a method of making the same) held by The Regents of the University of California expires Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 02 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K2039/522, A61K39/00, A61P, A61P31/04